125 related articles for article (PubMed ID: 2959559)
1. Induction of renal metallothionein allows increasing dose of an extensively used antitumor drug, cis-diamminedichloroplatinum.
Imura N; Naganuma A; Satoh M; Koyama Y
Experientia Suppl; 1987; 52():655-60. PubMed ID: 2959559
[TBL] [Abstract][Full Text] [Related]
2. Prevention of lethal and renal toxicity of cis-diamminedichloroplatinum(II) by induction of metallothionein synthesis without compromising its antitumor activity in mice.
Naganuma A; Satoh M; Imura N
Cancer Res; 1987 Feb; 47(4):983-7. PubMed ID: 3802104
[TBL] [Abstract][Full Text] [Related]
3. Citrate enhances the protective effect of orally administered bismuth subnitrate against the nephrotoxicity of cis-diamminedichloroplatinum.
Kondo Y; Himeno S; Satoh M; Naganuma A; Nishimura T; Imura N
Cancer Chemother Pharmacol; 2004 Jan; 53(1):33-8. PubMed ID: 14530870
[TBL] [Abstract][Full Text] [Related]
4. Metallothionein induction prevents toxic side effects of cisplatin and adriamycin used in combination.
Satoh M; Naganuma A; Imura N
Cancer Chemother Pharmacol; 1988; 21(2):176-8. PubMed ID: 3349566
[TBL] [Abstract][Full Text] [Related]
5. Protective role of metallothionein in renal toxicity of cisplatinum.
Satoh M; Aoki Y; Tohyama C
Cancer Chemother Pharmacol; 1997; 40(4):358-62. PubMed ID: 9225956
[TBL] [Abstract][Full Text] [Related]
6. Tissue-specific induction of metallothionein by bismuth as a promising protocol for chemotherapy with repeated administration of cis-diamminedichloroplatinum (II) against bladder tumor.
Kondo Y; Satoh M; Imura N; Akimoto M
Anticancer Res; 1992; 12(6B):2303-7. PubMed ID: 1295477
[TBL] [Abstract][Full Text] [Related]
7. Effect of bismuth nitrate given in combination with cis-diamminedichloroplatinum(II) on the antitumor activity and renal toxicity of the latter in nude mice inoculated with human bladder tumor.
Kondo Y; Satoh M; Imura N; Akimoto M
Cancer Chemother Pharmacol; 1991; 29(1):19-23. PubMed ID: 1742844
[TBL] [Abstract][Full Text] [Related]
8. Effect of coadministration of selenite on the toxicity and antitumor activity of cis-diamminedichloroplatinum (II) given repeatedly to mice.
Satoh M; Naganuma A; Imura N
Cancer Chemother Pharmacol; 1992; 30(6):439-43. PubMed ID: 1394800
[TBL] [Abstract][Full Text] [Related]
9. Modulation of both cisplatin nephrotoxicity and drug resistance in murine bladder tumor by controlling metallothionein synthesis.
Satoh M; Kloth DM; Kadhim SA; Chin JL; Naganuma A; Imura N; Cherian MG
Cancer Res; 1993 Apr; 53(8):1829-32. PubMed ID: 8467502
[TBL] [Abstract][Full Text] [Related]
10. Effect of preinduction of metallothionein synthesis on clastogenicity of anticancer drugs in mice.
Nakagawa I; Nishi E; Naganuma A; Imura N
Mutat Res; 1995 Sep; 348(1):37-43. PubMed ID: 7565913
[TBL] [Abstract][Full Text] [Related]
11. Interaction of cis- and trans-diamminedichloroplatinum with metallothionein in vivo.
Zhang B; Huang H; Tang W
J Inorg Biochem; 1995 Apr; 58(1):1-8. PubMed ID: 7738537
[TBL] [Abstract][Full Text] [Related]
12. Renal toxicity caused by cisplatinum in glutathione-depleted metallothionein-null mice.
Satoh M; Shimada A; Zhang B; Tohyama C
Biochem Pharmacol; 2000 Dec; 60(11):1729-34. PubMed ID: 11077056
[TBL] [Abstract][Full Text] [Related]
13. Specific reduction of toxic side effects of adriamycin by induction of metallothionein in mice.
Naganuma A; Satoh M; Imura N
Jpn J Cancer Res; 1988 Mar; 79(3):406-11. PubMed ID: 3131288
[TBL] [Abstract][Full Text] [Related]
14. Optimum schedule of selenium administration to reduce lethal and renal toxicities of cis-diamminedichloroplatinum in mice.
Satoh M; Naganuma A; Imura N
J Pharmacobiodyn; 1989 Apr; 12(4):246-53. PubMed ID: 2795434
[TBL] [Abstract][Full Text] [Related]
15. Modulation of adriamycin toxicity by tissue-specific induction of metallothionein synthesis in mice.
Satoh M; Naganuma A; Imura N
Life Sci; 2000 Jun; 67(6):627-34. PubMed ID: 12659168
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of dithiocarbamates against toxicity of cis-diamminedichloroplatinum in mice.
Shimada H; Takahashi K; Funakoshi T; Kojima S
Biol Pharm Bull; 1993 Apr; 16(4):368-71. PubMed ID: 8358386
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of metallothionein inducing metals on lethal toxicity of cis-diamminedichloroplatinum in mice.
Naganuma A; Satoh M; Koyama Y; Imura N
Toxicol Lett; 1985; 24(2-3):203-7. PubMed ID: 4039080
[TBL] [Abstract][Full Text] [Related]
18. The role of metallothionein in the reduction of cisplatin-induced nephrotoxicity by Bi3(+)-pretreatment in the rat in vivo and in vitro. Are antioxidant properties of metallothionein more relevant than platinum binding?
Boogaard PJ; Slikkerveer A; Nagelkerke JF; Mulder GJ
Biochem Pharmacol; 1991 Feb; 41(3):369-75. PubMed ID: 1994896
[TBL] [Abstract][Full Text] [Related]
19. Prevention of adverse effects of gamma-ray irradiation after metallothionein induction by bismuth subnitrate in mice.
Satoh M; Miura N; Naganuma A; Matsuzaki N; Kawamura E; Imura N
Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1727-31. PubMed ID: 2632256
[TBL] [Abstract][Full Text] [Related]
20. The interactions of cis-diamminedichloroplatinum with metallothionein and glutathione in rat liver and kidney.
Suzuki CA; Cherian MG
Toxicology; 1990 Nov; 64(2):113-27. PubMed ID: 1977210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
